UBS Group’s Leverage Shares 2x Long CRML Daily ETF CRMU Stock Holding History

UBS Group’s Portfolio CRMU Stock Details CRMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,577	Closed	-$8.65K	–	11646
2026 Q1	$8.65K	Buy	+1,577	New	+$13.2K	﹤0.01%	8498

Other funds holding CRMU

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

UBS Group's CRMU Position: Q2 2026 in Review

UBS Group sold out of Leverage Shares 2x Long CRML Daily ETF (CRMU) in Q2 2026, closing a stake of 1,577 shares — an estimated $8.65K sold.

UBS Group first reported a position in CRMU in Q1 2026 and held it in 1 quarter. The position peaked at $8.65K in Q1 2026. 1 fund tracked by Wall St. Rank holds CRMU as of Q2 2026.

UBS Group reported no remaining Leverage Shares 2x Long CRML Daily ETF position as of Q2 2026 after selling out during the quarter.
UBS Group sold 1,577 Leverage Shares 2x Long CRML Daily ETF shares in Q2 2026, an estimated $8.65K.
UBS Group first reported a position in Leverage Shares 2x Long CRML Daily ETF in Q1 2026 and held it in 1 quarter.
UBS Group's Leverage Shares 2x Long CRML Daily ETF position peaked at $8.65K in Q1 2026.
1 fund tracked by Wall St. Rank held Leverage Shares 2x Long CRML Daily ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.